Pharmacological enhancement of Ocimum secondary metabolites via Spirulina extract: A molecular perspective

Egyptian Pharmaceutical Journal · Published 2026-05-11 · DOI 10.21608/epj.2026.462150.1317

Authors (4)

Tasneem Y Abduallh, Shereen Abu El-Maaty, Mona H. Hussein, Reda E. A. Moghaieb

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Abduallh, T., El-Maaty, S., Hussein, M., et al. (2026). Pharmacological enhancement of Ocimum secondary metabolites via Spirulina extract: A molecular perspective. Egyptian Pharmaceutical Journal. https://doi.org/10.21608/epj.2026.462150.1317

Related articles

• Wound healing activity of Centella asiatica extract via inflammatory gene regulation in zebrafish (Danio rerio) · Egyptian Pharmaceutical Journal · 2026 · Same journal
• Phytase superior Lactobacillusisolate (L-Phy5) and its mutants: molecular identification · Egyptian Pharmaceutical Journal · 2025 · Same journal
• Next-Generation Topical Nanosuspension of HMG-CoA Reductase Inhibitors: A Novel Dermatological Approach Against Aging and Inflammation · Egyptian Pharmaceutical Journal · 2026 · Same journal
• Clinical and molecular characterization of patients with Gardner syndrome using whole exome sequencing · Egyptian Pharmaceutical Journal · 2025 · Same journal
• N-Acetylcysteine ameliorates the dysfunction of submandibular glands in type 1 diabetic rats via modulation of NF-κB, Nrf2, Bcl-2, and Caspase-3 · Egyptian Pharmaceutical Journal · 2026 · Same journal
• Synthesis, Characterization, and Antimicrobial Evaluation of a New Pyrazole-Oxadiazole Hybrid Derivatives · Egyptian Pharmaceutical Journal · 2026 · Same journal
• Production of Exopolysaccharides by Diverse Bacterial Strains Isolated from Cheese Whey · Egyptian Pharmaceutical Journal · 2025 · Same journal
• Ethanolic extract of Andrographis paniculata induces apoptosis and modulates autophagy in in lung cancer cells via the activation of reactive oxygen species formation: an in vitro study · Egyptian Pharmaceutical Journal · 2026 · Same journal
• Expression of miR-15a-5p, miR-17-5p, and miR-103-3p in hypertension-associated chronic kidney disease and hemodialysis patients · Egyptian Pharmaceutical Journal · 2025 · Same journal
• Computational investigation of daphnoretin as a potential matrix metalloproteinase-1 inhibitor: molecular docking, MM-GBSA, and molecular dynamics study · Egyptian Pharmaceutical Journal · 2026 · Same journal